Buy Aurobindo Pharma Ltd For Target Rs. 1,050
* We maintain Buy rating on Aurobindo and raise the TP to Rs1,050 from Rs1,000 after a good Q3 which saw healt..
Aurobindo Pharma is currently trading at Rs. 859.25, up by 3.25 points or 0.38% from its previous closing of Rs. 856.00 on the BSE.
The scrip opened at Rs. 869.00 and ..
* Strong momentum in injectables business to support US business as acceleration unlikely in slow growing oral solids
* Steady margin uptick over next 2 ye..
Religare Super Idea**
To Read Complete Report & Disclaimer Click Here
Please refer disclaimer http://ex.religareonline.com/disclaim..
Approval for 3 products under PLI Scheme
Aurobindo Pharma (Aurobindo) received approval from government of India for three fermentation based products under Productio..
Weekly future recommendation:
Select Pharma stocks remained in focus as Nifty rallied towards 14600 levels. On the weekly basis Pharma index ended almost..
Rupee falls 10 paise to 73.94 against US dollar in early trade
Rate decision, US stimulus likely constraints to rupee's further appreciation
NCLT approves sale of IL&FS education arm to LEHL
Hyundai Motor India adds new Board members
Vodafone Idea board to mull raising funds post AGR verdict
Stock Pick - Buy Cipla Ltd For Target Rs. 850 - HDFC Securities
IOC confirms Brisbane as preferred host for 2032 Olympics
Exxon Mobil's total reserves drop by a third after COVID-19 oil price drop
Axa posts 18% net income drop as COVID-19 claims weigh
© Copyright 2017 - investmentguruindia | All Rights Reserved. | Crafted By - Digi Interface